The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic Apr 25, 2023 | Lynch Syndrome, Uncategorized
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy Feb 24, 2022 | Uncategorized
The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex. Nov 27, 2018 | Uncategorized
